Exploration of the chondrosarcoma metabolome; the mTOR pathway as an important pro-survival pathway
Author:
Funder
Dutch Cancer Society
Rush University
University of Valencia
Publisher
Elsevier BV
Subject
Oncology
Reference47 articles.
1. Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading;Evans;Cancer,1977
2. Outcome of advanced, unresectable conventional central chondrosarcoma;van Maldegem;Cancer,2014
3. Advanced chondrosarcomas: role of chemotherapy and survival;Italiano;Ann. Oncol.,2013
4. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes;Levine;Science,2010
5. Metabolic targets for cancer therapy;Galluzzi;Nat. Rev. Drug Discov.,2013
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Global research development of chondrosarcoma from 2003 to 2022: a bibliometric analysis;Frontiers in Pharmacology;2024-08-02
2. IDH Mutations in Chondrosarcoma: Case Closed or Not?;Cancers;2023-07-13
3. Therapeutic Targets and Emerging Treatments in Advanced Chondrosarcoma;International Journal of Molecular Sciences;2022-01-20
4. Metabolic Pathways and Targets in Chondrosarcoma;Frontiers in Oncology;2021-12-06
5. Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations;Cell Reports Medicine;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3